DUBLIN--(BUSINESS WIRE)--The "Ablation Equipments - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.
This report provides an overview of Ablation Equipment currently in the pipeline stage.
It provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in pipeline product development. It also provides information about clinical trials in progress, which includes the trial phase, trial status, trial start, and end dates, and, the number of trials for the key Incontinence Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.
Reasons to buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ablation Equipments under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
-
In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
- Introduction
- Ablation Equipments Overview
- Products under Development
- Ablation Equipments - Pipeline Products by Stage of Development
- Ablation Equipments - Pipeline Products by Territory
- Ablation Equipments - Pipeline Products by Regulatory Path
- Ablation Equipments - Pipeline Products by Estimated Approval Date
- Ablation Equipments - Ongoing Clinical Trials
- Ablation Equipments - Pipeline Products under Development by Companies
- Ablation Equipments Companies - Pipeline Products by Stage of Development
- Ablation Equipments - Pipeline Products by Stage of Development
- Ablation Equipments Companies and Product Overview
- AngioDynamics Inc Company Overview
- AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
- Avenda Health Inc Company Overview
- Avenda Health Inc Pipeline Products & Ongoing Clinical Trials Overview
- CPSI Biotech Company Overview
- CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
- Creo Medical Ltd Company Overview
- Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- Deneb Medical SL Company Overview
- Deneb Medical SL Pipeline Products & Ongoing Clinical Trials Overview
- Ablation Equipments- Recent Developments
- Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
- Nov 15, 2019: Fractyl announces new data from Revita-1 clinical study showing durable benefits after a single treatment through two years of follow up
- Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
- Nov 08, 2019: Fractyl announces Revita-2 data showing Revita DMR provides statistically significant improvements in blood glucose and liver fat in type 2 diabetes with and without NAFLD
- Nov 06, 2019: Olympus unveils corporate strategy
- Appendix
-
Methodology
Companies Mentioned
- AngioDynamics Inc
- Avenda Health Inc
- CPSI Biotech
- Creo Medical Ltd
- Deneb Medical SL
- Elesta srl
- Ethicon US LLC
- Eximo Medical Ltd
- ExpandoHeat LLC
- Fractyl Laboratories Inc
- Harmonic Medical Inc
- HEPTA Medical SASU
- HistoSonics Inc
- Hospital for Special Surgery
- Integra LifeSciences Holdings Corp
- Intratherm LLC (Inactive)
- Massachusetts Institute of Technology
- Medtronic plc
- Memorial Sloan Kettering Cancer Center
- Mirabilis Medical Inc
- ProstaCare Pty Ltd
- Pulse Biosciences Inc
- Sabanci University Nanotechnology Research and Application Center
- Southern Illinois University Carbondale
- Thermedical Inc
- TransEnterix Inc
- University of California San Francisco
- University of Texas at Austin
- University of Wisconsin-Stout
-
Verix Health
For more information about this report visit https://www.researchandmarkets.com/r/y0yko2
